Regenxbio (RGNX) Enterprise Value (2014 - 2025)
Regenxbio's (RGNX) quarterly Enterprise Value came in at -$230.1 million in Q4 2025, up 1.97% year-on-year from -$225.6 million in Q4 2024, and up 16.1% quarter-over-quarter from -$274.2 million in Q3 2025.
Regenxbio (RGNX) Enterprise Value (2014 - 2025) Analysis & Trends
Regenxbio's Enterprise Value history runs 12 years deep, the most recent figure standing at -$230.1 million for Q4 2025.
- On a quarterly basis, Enterprise Value rose 1.97% year-over-year to -$230.1 million in Q4 2025; TTM through Dec 2025 was -$230.1 million, a 1.97% increase from a year earlier, with the FY2025 full-year figure at -$230.1 million, up 1.97% from the prior year.
- Enterprise Value rose to -$230.1 million in Q4 2025 per RGNX's latest filing, from -$274.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$230.1 million in Q4 2025 and bottomed at -$457.4 million in Q4 2021.
- The 5-year median for Enterprise Value is -$327.6 million (2023), against an average of -$330.0 million.
- Across the five-year window, Enterprise Value plunged 57.88% in 2021 and increased 24.51% in 2023, its largest moves.
- Year by year, Enterprise Value stood at -$457.4 million in 2021, then increased by 20.29% to -$364.6 million in 2022, then gained by 24.51% to -$275.3 million in 2023, then grew by 14.74% to -$234.7 million in 2024, then grew by 1.97% to -$230.1 million in 2025.
- Per Business Quant, the three latest RGNX Enterprise Value figures stand at -$230.1 million (Q4 2025), -$274.2 million (Q3 2025), and -$323.3 million (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Regenxbio | 528.62 Mn | 298.55 Mn | 21.22 Mn | -230.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -230.07 Mn |
| Sep 30, 2025 | -274.21 Mn |
| Jun 30, 2025 | -323.30 Mn |
| Mar 31, 2025 | -267.87 Mn |
| Dec 31, 2024 | -234.69 Mn |
| Sep 30, 2024 | -255.46 Mn |
| Jun 30, 2024 | -290.36 Mn |
| Mar 31, 2024 | -338.70 Mn |
| Dec 31, 2023 | -275.26 Mn |
| Sep 30, 2023 | -301.89 Mn |
| Jun 30, 2023 | -320.08 Mn |
| Mar 31, 2023 | -331.82 Mn |
| Dec 31, 2022 | -364.64 Mn |
| Sep 30, 2022 | -382.42 Mn |
| Jun 30, 2022 | -402.96 Mn |
| Mar 31, 2022 | -394.13 Mn |
| Dec 31, 2021 | -457.44 Mn |
| Sep 30, 2021 | -339.86 Mn |
| Jun 30, 2021 | -374.74 Mn |
| Mar 31, 2021 | -440.88 Mn |